首页> 美国卫生研究院文献>Autophagy >Leucine-rich repeat (LRR) proteins
【2h】

Leucine-rich repeat (LRR) proteins

机译:富含亮氨酸的重复(LRR)蛋白

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The leucine-rich repeats (LRR)-containing domain is evolutionarily conserved in many proteins associated with innate immunity in plants, invertebrates and vertebrates. Serving as a first line of defense, the innate immune response is initiated through the sensing of pathogen-associated molecular patterns (PAMPs). In plants, NBS (nucleotide-binding site)-LRR proteins provide recognition of pathogen products of avirulence (AVR) genes. LRRs also promote interaction between LRR proteins as observed in receptor-coreceptor complexes. In mammals, toll-like receptors (TLRs) and NOD-like receptors (NLRs) through their LRR domain, sense molecular determinants from a structurally diverse set of bacterial, fungal, parasite and viral-derived components. In humans, at least 34 LRR proteins are implicated in diseases. Most LRR domains consist of 2–45 leucine-rich repeats, with each repeat about 20–30 residues long. Structurally, LRR domains adopt an arc or horseshoe shape, with the concave face consisting of parallel β-strands and the convex face representing a more variable region of secondary structures including helices. Apart from the TLRs and NLRs, most of the 375 human LRR proteins remain uncharacterized functionally. We incorporated computational and functional analyses to facilitate multifaceted insights into human LRR proteins and outline a few approaches here.
机译:富含亮氨酸重复序列(LRR)的域在许多与植物,无脊椎动物和脊椎动物的先天免疫相关的蛋白质中在进化上是保守的。作为第一道防线,先天免疫应答通过感测病原体相关分子模式(PAMP)引发。在植物中,NBS(核苷酸结合位点)-LRR蛋白可识别无毒(AVR)基因的病原体产物。如受体-受体复合体中所观察到的,LRR还促进LRR蛋白之间的相互作用。在哺乳动物中,通过其LRR结构域的Toll样受体(TLR)和NOD样受体(NLR)从结构多样的细菌,真菌,寄生虫和病毒衍生成分中检测分子决定簇。在人类中,至少有34种LRR蛋白与疾病有关。大多数LRR结构域由2-45个富含亮氨酸的重复序列组成,每个重复序列约长20-30个残基。在结构上,LRR域呈弧形或马蹄形,其凹面由平行的β链组成,而凸面则代表包括螺旋的二级结构的可变区。除TLR和NLR外,375种人类LRR蛋白中的大多数仍未表征。我们结合了计算和功能分析,以促进对人LRR蛋白的多方面见解,并在此处概述了几种方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号